Phase I-Ib trial of tivantinib in combination with carboplatin and pemetrexed as first-line treatment in patients (pts) with advanced nonsquamous NSCLC or malignant pleural mesothelioma (MPM).
Paolo A. Zucali
No relevant relationships to disclose
Matteo Simonelli
No relevant relationships to disclose
Fabio De Vincenzo
No relevant relationships to disclose
Giuseppe Fatuzzo
No relevant relationships to disclose
Monica Bertossi
No relevant relationships to disclose
Matteo B. Suter
No relevant relationships to disclose
Matteo Perrino
No relevant relationships to disclose
Laura Giordano
No relevant relationships to disclose
Armando Santoro
No relevant relationships to disclose